GL1X · GenesisL1 explorer

MolNFT v1 · #154101 · protein

Crystal structure of REV7(R124A) in complex with a SHIELDIN3 fragment

6K07 · Mitotic spindle assembly checkpoint protein MAD2B: “Crystal structure of REV7(R124A) in complex with a SHIELDIN3 fragment”. X-ray diffraction, 1 ligand (SO4), 1 pocket (best druggability 0.26). MolNFT v1 #154101 on GenesisL1: 3D…

PDB
6K07
Type
protein
Length
224 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitotic spindle assembly checkpoint protein MAD2B; Shieldin complex subunit 3
UniProt
Q9UI95, Q6ZNX1
Ligands
SO4
Pockets
1 · best druggability 0.26

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitotic spindle assembly checkpoint protein MAD2Bprotein19935% helix, 30% strandQ9UI95
BShieldin complex subunit 3protein2540% helix, 12% strandQ6ZNX1

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1520.260.7419empty

Interfaces

1 interface between chains.

  • A–B · 1172 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 6K07 · Crystal structure of REV7(R124A) in complex with a Shieldin3 fragment · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UI95 · AlphaFold monomer V2.0 prediction for mitotic spindle assembly checkpoint protein MAD2B… · a predicted model of the same protein · chain A against A, TM-score 0.97
  • Q6ZNX1 · AlphaFold monomer V2.0 prediction for shieldin complex subunit 3 (Q6ZNX1) · a predicted model of the same protein · chain B against A, TM-score 0.46

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.